Clinical Trial Update: Bioequivalence Study of Pediatric Formulations to Treat HIV Infection [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of pediatric formulations for HIV infection is being conducted, with unknown status at the time of reporting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Pediatric HIV formulation (bioequivalence study)

Snippet

Sponsor: Elim Pediatric Pharmaceuticals Inc. | Conditions: HIV, AIDS | Phase 1 | Status: UNKNOWN